Last month, Novartis’s CAR-T cell therapy CTL-019 has unanimously (10-0) won a recommended approval from FDA advisory committee to treat pediatric, young adult r/r B-cell ALL, marking one big step closer to reaching patients. The vote represents a pivotal milestone for this class of experimental treatment. The FDA is expected to make a final decision …
In 2017, a series of events have drawn national and international attentions to CAR-T therapy, making it one of the hottest topic of the year. In January, Shanghai Fosun and Kite Pharma has formed a joint venture, with each holding 50% stake. In February, Juno has announced to discontinue its JCAR015 trail and began to …
In recent years, merger and acquisition (M&A) has been the dominant theme in the Chinese healthcare and pharmaceutical industry, especially in the field of in vitro diagnostics (IVD). A number of companies have undergone acquisitions and this trend will continue to grow in 2018. This integration phenomenon has raised new requirements and challenges for large customer-oriented central …
According to World Health Organization, cancer is the second leading cause of death globally in the past decade; however, it is rapidly gaining ground as the No.1 killer. About 14 million new cases emerge annually worldwide, which results in around 8.8 million deaths yearly — a mortality rate as high as 63%! Although cancer …
The American Society of Clinical Oncology (ASCO) conference, the biggest global annual event of cancer research, is considered as the “Super Bowl” of the pharmaceutical and biotechnology industry. Every year, people from all over the world come here to showcase their most promising clinical trial data to the public, no matter they are major pharma …
Recently, China Food and Drug Administration (CFDA) has submitted its membership application to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (also known as the International Council for Harmonisation or ICH), marked its integration into the internationally recognized regulatory system. ICH was co-launched by regulatory agencies and industry associations from …
Your guide of the Chinese pharmaceutical industry Please feel free to contact me about any questions of the Chinese pharmaceutical market! I am the pharmaceutical consultant for China! Thank you for coming to my blog! I am the pharmaceutical consultant of the Chinese pharmaceutical and healthcare industry. If you are interested in learning more and …